company background image
ALBIO logo

Biosynex ENXTPA:ALBIO Stock Report

Last Price

€2.82

Market Cap

€30.3m

7D

0%

1Y

-63.6%

Updated

20 Nov, 2024

Data

Company Financials

Biosynex SA

ENXTPA:ALBIO Stock Report

Market Cap: €30.3m

ALBIO Stock Overview

Designs, manufactures, and distributes rapid diagnostic tests in France and internationally. More details

ALBIO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Risk Analysis

Debt is not well covered by operating cash flow

Earnings have declined by 25.5% per year over past 5 years

Highly volatile share price over the past 3 months compared to the French market

Shareholders have been diluted in the past year

+ 1 more risk

Biosynex SA Competitors

Laboratoires Euromedis Société anonyme

ENXTPA:ALEMG

€13.0m

Theradiag

ENXTPA:ALTER

€16.4m

Ikonisys

ENXTPA:ALIKO

€16.7m

Theraclion

ENXTPA:ALTHE

€15.7m

Price History & Performance

Summary of all time highs, changes and price drops for Biosynex
Historical stock prices
Current Share Price€2.82
52 Week High€8.97
52 Week Low€2.66
Beta-2.08
11 Month Change-17.06%
3 Month Change-53.23%
1 Year Change-63.61%
33 Year Change-85.32%
5 Year Change6.02%
Change since IPO-84.29%

Recent News & Updates

Benign Growth For Biosynex SA (EPA:ALBIO) Underpins Stock's 27% Plummet

Oct 30
Benign Growth For Biosynex SA (EPA:ALBIO) Underpins Stock's 27% Plummet

Biosynex SA's (EPA:ALBIO) Shares Bounce 28% But Its Business Still Trails The Industry

Aug 16
Biosynex SA's (EPA:ALBIO) Shares Bounce 28% But Its Business Still Trails The Industry

Biosynex SA (EPA:ALBIO) Not Doing Enough For Some Investors As Its Shares Slump 30%

Jun 29
Biosynex SA (EPA:ALBIO) Not Doing Enough For Some Investors As Its Shares Slump 30%

Recent updates

Benign Growth For Biosynex SA (EPA:ALBIO) Underpins Stock's 27% Plummet

Oct 30
Benign Growth For Biosynex SA (EPA:ALBIO) Underpins Stock's 27% Plummet

Biosynex SA's (EPA:ALBIO) Shares Bounce 28% But Its Business Still Trails The Industry

Aug 16
Biosynex SA's (EPA:ALBIO) Shares Bounce 28% But Its Business Still Trails The Industry

Biosynex SA (EPA:ALBIO) Not Doing Enough For Some Investors As Its Shares Slump 30%

Jun 29
Biosynex SA (EPA:ALBIO) Not Doing Enough For Some Investors As Its Shares Slump 30%

Biosynex SA (EPA:ALBIO) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Mar 12
Biosynex SA (EPA:ALBIO) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Biosynex SA's (EPA:ALBIO) Shares Not Telling The Full Story

Jan 20
Biosynex SA's (EPA:ALBIO) Shares Not Telling The Full Story

Returns On Capital Are Showing Encouraging Signs At Biosynex (EPA:ALBIO)

May 05
Returns On Capital Are Showing Encouraging Signs At Biosynex (EPA:ALBIO)

Investors Shouldn't Overlook Biosynex's (EPA:ALBIO) Impressive Returns On Capital

Dec 01
Investors Shouldn't Overlook Biosynex's (EPA:ALBIO) Impressive Returns On Capital

Biosynex (EPA:ALBIO) Could Easily Take On More Debt

Jun 23
Biosynex (EPA:ALBIO) Could Easily Take On More Debt

If You Like EPS Growth Then Check Out Biosynex (EPA:ALBIO) Before It's Too Late

Jul 11
If You Like EPS Growth Then Check Out Biosynex (EPA:ALBIO) Before It's Too Late

Here's Why I Think Biosynex (EPA:ALBIO) Is An Interesting Stock

Apr 06
Here's Why I Think Biosynex (EPA:ALBIO) Is An Interesting Stock

We Think Biosynex (EPA:ALBIO) Can Stay On Top Of Its Debt

Dec 19
We Think Biosynex (EPA:ALBIO) Can Stay On Top Of Its Debt

Shareholder Returns

ALBIOFR Medical EquipmentFR Market
7D0%2.7%-0.3%
1Y-63.6%26.7%-3.5%

Return vs Industry: ALBIO underperformed the French Medical Equipment industry which returned 28.4% over the past year.

Return vs Market: ALBIO underperformed the French Market which returned -2.5% over the past year.

Price Volatility

Is ALBIO's price volatile compared to industry and market?
ALBIO volatility
ALBIO Average Weekly Movement9.2%
Medical Equipment Industry Average Movement5.4%
Market Average Movement4.5%
10% most volatile stocks in FR Market9.2%
10% least volatile stocks in FR Market2.2%

Stable Share Price: ALBIO's share price has been volatile over the past 3 months compared to the French market.

Volatility Over Time: ALBIO's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of French stocks.

About the Company

FoundedEmployeesCEOWebsite
1993515Larry Abensurwww.biosynex.com

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers medical devices for in vitro diagnosis in the form of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women’s health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers, oxymeters, and blood pressure monitors; and oral care and medical aid products.

Biosynex SA Fundamentals Summary

How do Biosynex's earnings and revenue compare to its market cap?
ALBIO fundamental statistics
Market cap€30.35m
Earnings (TTM)-€38.48m
Revenue (TTM)€104.07m

0.3x

P/S Ratio

-0.8x

P/E Ratio

Is ALBIO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALBIO income statement (TTM)
Revenue€104.07m
Cost of Revenue€49.01m
Gross Profit€55.06m
Other Expenses€93.54m
Earnings-€38.48m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-3.58
Gross Margin52.91%
Net Profit Margin-36.97%
Debt/Equity Ratio59.6%

How did ALBIO perform over the long term?

See historical performance and comparison